However, the implementation and progress of your government programmes associated with the Pepfar funding have been suboptimal and are insufficient to reach epidemic control. You have dodged the big question. There has been a decline in the number of people testing and enrolling in programmes, and then dropping out of the treatment. Nothing is being done in that area and this poses a significant risk, where many of the successes you have spoken about could well be reversed, not to mention the potential loss of funds.